(Q38263089)

1 September 2017

1 reference

title

Cardiac MRI: a central prognostic tool in myocardial fibrosis (English)

1 reference

1 September 2017

0 references

Bharath Ambale-Venkatesh

series ordinal

1

1 reference

1 September 2017

João A C Lima

series ordinal

2

1 reference

1 September 2017

language of work or name

English

0 references

publication date

28 October 2014

1 reference

Nature Reviews Cardiology

1 September 2017

published in

1 reference

1 September 2017

volume

12

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

18-29

1 reference

Myofibroblast-mediated mechanisms of pathological remodelling of the heart

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

The pathogenesis of cardiac fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Assessment of myocardial fibrosis with cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocyte renewal and ventricular remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial fibrosis: functional significance and regulatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Effects of myocardial water exchange on T1 enhancement during bolus administration of MR contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Mechanism of late gadolinium enhancement in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Determining myocardial viability in myocardial infarct. Comparison of single and multisclice MRI techniques with TurboFlash and TrueFISP sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Measuring myocardial scar by CMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Prevalence and prognosis of myocardial scar in patients with known or suspected coronary artery disease and normal wall motion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magne

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison with single-photon emission tomography using Tc99m-Sestamibi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Major prognostic impact of persistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reperfused acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Infarct morphology identifies patients with substrate for sustained ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation .

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Association of longitudinal changes in left ventricular structure and function with myocardial fibrosis: the Multi-Ethnic Study of Atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort: the Multi-Ethnic Study of Atherosclerosis (MESA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial structure, function, and scar in patients with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Heart-rate independent myocardial T1-mapping using combined saturation and inversion preparation pulses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Three-dimensional Look-Locker MRI for evaluation of postcontrast myocardial and blood T1 values: comparison with two-dimensional Look-Locker and late gadolinium enhancement MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Multiple 3D inversion recovery imaging for volume T1 mapping of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Phase-sensitive inversion recovery for myocardial T1 mapping with motion correction and parametric fitting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

3D myocardial T1 mapping at 3T using variable flip angle method: pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Pharmacokinetic modeling of delayed gadolinium enhancement in the myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Modified look-locker inversion recovery T1 mapping indices: assessment of accuracy and reproducibility between magnetic resonance scanners

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Associations between fibrocytes and postcontrast myocardial T1 times in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Gender differences and aging: effects on the human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Why are women more likely than men to develop heart failure with preserved ejection fraction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T₁ mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Cardiac magnetic resonance T1 mapping of left atrial myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echo-planar MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Prognostic Value of Myocardial Viability by Delayed-Enhanced Magnetic Resonance in Patients With Coronary Artery Disease and Low Ejection Fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

In-vivo assessment of normal T1 values of the right-ventricular myocardium by cardiac MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Circulating biomarkers of collagen type I metabolism mark the right ventricular fibrosis and adverse markers of clinical outcome in adults with repaired tetralogy of Fallot

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Acute Left Ventricular Remodeling Following Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Late Gadolinium Enhancement Magnetic Resonance Imaging in the Diagnosis and Prognosis of Endomyocardial Fibrosis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocyte cell loss and myocyte hypertrophy in the aging rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Gadolinium pharmacokinetics of chronic myocardial infarcts: Implications for late gadolinium-enhanced infarct imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

An improved MR imaging technique for the visualization of myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Presentation, patterns of myocardial damage, and clinical course of viral myocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Prognostic value of late gadolinium enhancement in hypertensive patients with known or suspected coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Multi-ethnic study of atherosclerosis: association between left atrial function using tissue tracking from cine MR imaging and myocardial fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Instantaneous signal loss simulation (InSiL): an improved algorithm for myocardial T₁ mapping using the MOLLI sequence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Diffuse myocardial fibrosis by post-contrast T1-time predicts outcome in heart failure with preserved ejection fraction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.159

Automated scar quantification by CMR: a step in the right direction.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25348690

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCARDIO.2014.159

1 reference

1 September 2017

1 reference